Összefoglaló közlemények / Review
Frequency of iron deficiency anemia in inflammatorybowel disease
Summary Introduction: A leading cause of iron deficiency anemia is inflammatory bowel disease, and it’s often an untreated complication that impair quality of life. It’s often accompanied by mild symptoms (fatigue, lethargy), in severe cases dyspnoea and mental disorders can occur. Anemia develops through several pathomechanisms, so, it’s recommended to clarify the underlying pathological processes.Aim: We examined the incidence of anemia/iron metabolic disorders, whether they occur more frequently during disease activity than at remission, and whether there is a significant difference between laboratory parameters and the incidence of anemia and iron metabolism abnormalities in two hospitals treating patients with different degrees of severity.
Kongresszusi összefoglaló / Congress report
Gastro Update Europe 2020 Meeting report of Gastro Update Europe 2020, September 4–5, 2020
This narrative review summarizes a selection of clinically-important novel gastrointestinal developments, presented and discussed at the virtual Gastro Update Europe.The selected topics, fully referenced, reflect what the distinguished faculty considered of vital importance to be communicated to the astute busy gastro-hep clinician who is eager to stay abreast of important novel developments. Whenever appropriate a personal comment or addition was added to further raise the educational value of this review. Given its narrative character, statements and conclusions are largely expert opinion-based, and referencing within this summary is limited to the included slide images.
Összefoglaló közlemények / Reviews
Liver transplantation
Liver transplantation is the only treatment in end-stage liver disease and acute liver failure which can provide a long-term survival. The average 5-year survival rate after liver transplantation is around 80%. The results of the liver transplantation in Hungary also reflect the good international statistics. The introduction of personalized immunosuppressive therapy may have a great importance in further improving graft and patient survival.
Magyar konszenzusajánlás / National guideline
Screening, diagnosis, treatment, and follow up of hepatitis C virus infection. National consensus guideline in Hungary from 23 September 2020.
Hepatitis C viral (HCV) infection is curable. Eradication of the virus is beneficial and essential from both individual as well as from social aspects. Treatment depends on availability and reimbursement of approved drugs in Hungary, and is based on a national consensus guideline, updated six-monthly. If no contraindication, demonstration of viral replication is the indication of therapy. Interferon-based treatments are not used any longer, an adequate and available interferon-free and preferably ribavirin-free therapy is to be applied. These are reimbursed for most diagnosed patients. Sequence of treatment initiation is determined by stage of fibrosis and by other (epidemiological, occupational etc.) factors, according to a priority scoring system.